| PRSS16 expression based on | ||||||||||||||||||||||||||||||||||||||
PAAD : Pancreatic adenocarcinoma*
Please note that low number(<10) of normal samples considered.
| ||||||||||||||||||||||||||||||||||||||
PAAD : Pancreatic adenocarcinoma*
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
| ||||||||||||||||||||||||||||||||||||||
PAAD : Pancreatic adenocarcinoma*
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
| ||||||||||||||||||||||||||||||||||||||
PAAD : Pancreatic adenocarcinoma*
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
| ||||||||||||||||||||||||||||||||||||||
PAAD : Pancreatic adenocarcinoma*
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
| ||||||||||||||||||||||||||||||||||||||
PAAD : Pancreatic adenocarcinoma*
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
| ||||||||||||||||||||||||||||||||||||||
PAAD : Pancreatic adenocarcinoma
| ||||||||||||||||||||||||||||||||||||||
PAAD : Pancreatic adenocarcinoma*
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
| ||||||||||||||||||||||||||||||||||||||
PAAD : Pancreatic adenocarcinoma*
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
| ||||||||||||||||||||||||||||||||||||||
PAAD : Pancreatic adenocarcinoma*
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
| ||||||||||||||||||||||||||||||||||||||
PAAD : Pancreatic adenocarcinoma*
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
| ||||||||||||||||||||||||||||||||||||||